Literature DB >> 34899936

Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19.

Abdolkarim Mahrooz1,2.   

Abstract

Entities:  

Year:  2021        PMID： 34899936      PMCID： PMC8607179          DOI： 10.4103/jrms.JRMS_1063_20

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN： 1735-1995            Impact factor:   1.852


× No keyword cloud information.
  6 in total

1.  Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients.

Authors:  Pawel Bogdanski; Joanna Suliburska; Monika Szulinska; Marta Stepien; Danuta Pupek-Musialik; Anna Jablecka
Journal:  Nutr Res       Date:  2012-06-20       Impact factor: 3.315

2.  Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits.

Authors:  Shitao Rao; Alexandria Lau; Hon-Cheong So
Journal:  Diabetes Care       Date:  2020-05-19       Impact factor: 19.112

Review 3.  COVID-19 and the endocrine system: exploring the unexplored.

Authors:  R Pal; M Banerjee
Journal:  J Endocrinol Invest       Date:  2020-05-02       Impact factor: 4.256

Review 4.  Obesity and impaired metabolic health in patients with COVID-19.

Authors:  Norbert Stefan; Andreas L Birkenfeld; Matthias B Schulze; David S Ludwig
Journal:  Nat Rev Endocrinol       Date:  2020-07       Impact factor: 43.330

5.  Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19.

Authors:  Sergey A Kornilov; Isabelle Lucas; Kathleen Jade; Chengzhen L Dai; Jennifer C Lovejoy; Andrew T Magis
Journal:  Crit Care       Date:  2020-07-22       Impact factor: 9.097

Review 6.  COVID-19 and diabetes: Knowledge in progress.

Authors:  Akhtar Hussain; Bishwajit Bhowmik; Nayla Cristina do Vale Moreira
Journal:  Diabetes Res Clin Pract       Date:  2020-04-09       Impact factor: 8.180
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.